Other Events ·
Standard BioTools Inc. received a notification from Nasdaq on July 22, 2026, stating the company failed to meet the…
LABStandard Biotools Inc.
Standard BioTools Inc. received a notification from Nasdaq on July 22, 2026, stating the company failed to meet the minimum bid price requirement for continued listing on the Nasdaq Global Select Market. The deficiency occurred because the share price closed below $1.00 for 30 consecutive business days. The company has a 180-day compliance period ending January 19, 2027, to restore compliance by maintaining a minimum bid price for at least 10 consecutive business days. Trading of the common stock under the ticker LAB remains uninterrupted. Standard BioTools Inc. is a life sciences company providing tools and instruments for biological research.